Run Du Group: Isosorbide Dinitrate Tablets Obtained Drug Registration Certificate

On May 12, Run Du Co., Ltd. announced that the company recently received the "Drug Registration Certificate" issued by the National Medical Products Administration, approving the registration of Isosorbide Mononitrate Tablets. This drug is suitable for the long-term treatment of coronary heart disease, and the prevention of angina pectoris. Obtaining the drug registration certificate this time will further enrich the company's product line, enhance market competitiveness, and have a positive impact on the company's future business performance. However, the future market sales of this drug may be affected by industry policies, tender procurement, and other factors, leading to uncertainty.